LPCN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Lipocine Inc (LPCN) is not a strong buy at this moment for a beginner investor with a long-term horizon. The stock lacks clear upward momentum, significant positive catalysts, or strong trading signals. While the analyst rating is favorable with a raised price target, the technical indicators and financial performance do not suggest a compelling entry point currently.
The MACD histogram is negative and contracting (-0.262), indicating weak momentum. RSI is neutral at 45.667, showing no overbought or oversold conditions. Moving averages are converging, suggesting indecision in price movement. Key support and resistance levels are Pivot: 8.509, R1: 9.159, S1: 7.858, R2: 9.561, S2: 7.457.
H.C. Wainwright raised the price target to $15 from $7 and maintained a Buy rating, citing a favorable safety profile for LPCN 1154.
No significant hedge fund or insider trading trends. No recent news or congress trading data. Financial performance shows improvement in net income and EPS YoY but remains negative overall.
In Q3 2025, revenue remained flat YoY at $114,574. Net income improved by 43.63% YoY but is still negative at -$3,186,832. EPS improved by 43.90% YoY to -0.59. Gross margin is 100%, unchanged YoY.
H.C. Wainwright raised the price target to $15 from $7 and maintained a Buy rating, citing LPCN 1154's favorable safety profile.
